Investigations, findings, and follow-up in patients with chest pain and elevated high-sensitivity cardiac troponin T levels but no myocardial infarction

International Journal of Cardiology

Volumn 232, Issue , 2017, Pages 111-116

  Roos, Andreas ^a,b   Hellgren, Anton ^a,b   Rafatnia, Farshid ^b,c   Hammarsten, Ola ^d   Ljung, Rickard ^b   Carlsson, Axel C ^b,e   Holzmann, Martin J ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUTHERAN MEDICAL CENTER   (United States)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

Emergency department; High sensitivity cardiac troponin T; No myocardial infarction; Normal level

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN T; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; SWEDE (PEOPLE); THORAX PAIN; UNIVERSITY HOSPITAL; BLOOD; DIFFERENTIAL DIAGNOSIS; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SWEDEN; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; SWEDEN; TROPONIN T;

EID: 85012965380     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2017.01.044     Document Type: Article

References (35)

1. [1] Goodacre, S., Cross, E., Arnold, J., Angelini, K., Capewell, S., Nicholl, J., The health care burden of acute chest pain. Heart 91 (2005), 229–230.
2. [2] Nawar, E.W., Niska, R.W., Xu, J., National Hospital Ambulatory Medical Care Survey: 2007 emergency department. Natl. Health Stat. Rep. 26 (Aug 6 2010), 1–31 (1-31).
3. [3] Hamm, C.W., Goldmann, B.U., Heeschen, C., Kreymann, G., Berger, J., Meinertz, T., Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N. Engl. J. Med. 337 (1997), 1648–1653.
4. [4] Morrow, D.A., Cannon, C.P., Jesse, R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007), 356–375.
5. [5] Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
6. [6] Roffi, M., Patrono, C., Collet, J.P., et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients. Eur. Heart J. 37 (2016), 267–315.
7. [7] Body, R., Carley, S., McDowell, G., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J. Am. Coll. Cardiol. 58 (2011), 1332–1339.
8. [8] Reichlin, T., Hochholzer, W., Bassetti, S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361 (2009), 858–867.
9. [9] Saenger, A.K., Beyrau, R., Braun, S., et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412 (2011), 748–754.
10. [10] Giannitsis, E., Kurz, K., Hallermayer, K., Jarausch, J., Jaffe, A.S., Katus, H.A., Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 56 (2010), 254–261.
11. [11] Korley, F.K., Schulman, S.P., Sokoll, L.J., et al. Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance. Acad. Emerg. Med. 21 (2014), 727–735.
12. [12] Chatterjee, S., Kim, J., Dahhan, A., Choudhary, G., Sharma, S., Wu, W.C., Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-analysis. Clin. Cardiol. 36 (2013), 649–653.
13. [13] Giannitsis, E., Becker, M., Kurz, K., Hess, G., Zdunek, D., Katus, H.A., High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin. Chem. 56 (2010), 642–650.
14. [14] Mokhtari, A., Lindahl, B., Smith, J.G., Holzmann, M.J., Khoshnood, A., Ekelund, U., Diagnostic accuracy of high-sensitivity cardiac troponin T at presentation combined with history and ECG for ruling out major adverse cardiac events. Ann Emerg Med. 68 (2016), 649–658.
15. [15] Hammarsten, O., Fu, M.L., Sigurjonsdottir, R., et al. Troponin T percentiles from a random population sample, emergency room patients. Clin. Chem. 58 (2012), 628–637.
16. [16] Omland, T., de Lemos, J.A., Sabatine, M.S., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361 (2009), 2538–2547.
17. [17] Latini, R., Masson, S., Anand, I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 116 (2007), 1242–1249.
18. [18] Hoiseth, A.D., Neukamm, A., Karlsson, B.D., Omland, T., Brekke, P.H., Soyseth, V., Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 66 (2011), 775–781.
19. [19] Filusch, A., Giannitsis, E., Katus, H.A., Meyer, F.J., High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clin. Sci. 119 (2010), 207–213.
20. [20] Wallace, T.W., Abdullah, S.M., Drazner, M.H., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 113 (2006), 1958–1965.
21. [21] Sundstrom, J., Ingelsson, E., Berglund, L., et al. Cardiac troponin-I and risk of heart failure: a community-based cohort study. Eur. Heart J. 30 (2009), 773–781.
22. [22] Saunders, J.T., Nambi, V., de Lemos, J.A., et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 123 (2011), 1367–1376.
23. [23] Bandstein, N., Ljung, R., Johansson, M., Holzmann, M.J., Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of MI. J. Am. Coll. Cardiol. 63 (2014), 2569–2578.
24. [24] Ludvigsson, J.F., Andersson, E., Ekbom, A., et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.
25. [25] Ingelsson, E., Arnlov, J., Sundstrom, J., Lind, L., The validity of a diagnosis of heart failure in a hospital discharge register. Eur. J. Heart Fail. 7 (2005), 787–791.
26. [26] Amsterdam, E.A., Wenger, N.K., Brindis, R.G., et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines., 130, 2014, 2354–2394.
27. [27] Ahmed, A.N., Blonde, K., Hackam, D., Iansavichene, A., Mrkobrada, M., Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis. Ann. Med. 46 (2014), 653–663.
28. [28] Sara, J.D., Holmes, D.R. Jr., Jaffe, A.S., Fundamental concepts of effective troponin use: important principles for internists. Am. J. Med. 128 (2015), 111–119.
29. [29] Collinson, P.O., Heung, Y.M., Gaze, D., et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin. Chem. 58 (2012), 219–225.
30. [30] Koerbin, G., Abhayaratna, W.P., Potter, J.M., et al. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin. Biochem. 46 (2013), 1636–1643.
31. [31] Bjurman, C., Petzold, M., Venge, P., Farbemo, J., Fu, M.L., Hammarsten, O., High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. Clin. Biochem. 48 (2015), 302–307.
32. [32] de Lemos, J.A., Drazner, M.H., Omland, T., et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304 (2010), 2503–2512.
33. [33] Hussein, A.A., Gottdiener, J.S., Bartz, T.M., Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the cardiovascular health study. J. Am. Coll. Cardiol. 62 (2013), 2112–2120.
34. [34] Otsuka, T., Kawada, T., Ibuki, C., Seino, Y., Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease. Am. Heart J. 159 (2010), 972–978.
35. [35] Wettermark, B., Hammar, N., Fored, C.M., et al. The new Swedish prescribed drug register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol. Drug Saf. 16 (2007), 726–735.